Tevogen Bio Inc.

1.02
-0.03 (-2.86%)
At close: Apr 16, 2025, 9:56 AM

Tevogen Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
-9.44M -5.88M -9.66M 11.26M -828.92K -278.75K -22.18M -30.76M 2.61M 1.61M 207K -25.99K -17.33K
103.55K 218.93K -17.2K 98.3K 259.15K 39.73K -11.74K 91.21K 196.06K 2.1K n/a n/a n/a
7.96M 3.33M 3.14M 26.33M n/a n/a n/a n/a 720.82K 1.26M n/a n/a n/a
1.35M -320.71K -80.03K -1.18M -187.57K 91.39K -80.54K 142.39K 160.25K 83.82K 242.31K 80.22K -571.78K
-2.38M -318.49K 3.64M -40.41M 40.05K -633.34K 20.1M 28.43M -2.87M -1.88M -435.96K -346.52K -201.61K
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
710.77K -1.15M -80.03K 517.84K -46.2K 397.51K -125.87K 55.8K 198.93K 156.23K 212.69K 169.84K -533.33K
-3.05M -3.8M -2.98M -2.16M -693.71K -208.46K -2.22M -2.18M -13.86K -42.6K -45.9K -113.03K -713.83K
n/a n/a n/a n/a n/a n/a n/a -133K -165.39K -126.64K n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a -67.5K n/a n/a n/a n/a n/a n/a n/a -351.9M
n/a n/a n/a n/a 9.71M n/a n/a 333.27M n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a 9.65M n/a n/a -133K -165.39K -126.64K n/a n/a -351.9M
n/a n/a n/a n/a 350K 1.15M 901K 2.5M 2.5M n/a n/a n/a n/a
-333.6M 333.6M n/a n/a -9.71M -333.27M n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
11M 1M n/a 229.33K 72.5K -200K n/a n/a n/a n/a n/a n/a n/a
2M 5M 2.8M 2.43M -9.29M 950K 901K 2.5M 2.5M n/a n/a n/a 352.96M
-1.05M 1.2M -182.51K 265.5K -338.71K -208.46K -2.22M 189.87K -13.86K -42.6K -45.9K -113.03K 344.58K
-3.05M -3.8M -2.98M -2.16M -693.71K -208.46K -2.22M -2.31M -179.25K -169.24K -45.9K -113.03K -713.83K